IBDEI1J3 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25939,0)
 ;;=G91.2^^98^1213^26
 ;;^UTILITY(U,$J,358.3,25939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25939,1,3,0)
 ;;=3^NPH w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,25939,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,25939,2)
 ;;=^5004174^F02.81
 ;;^UTILITY(U,$J,358.3,25940,0)
 ;;=G91.2^^98^1213^27
 ;;^UTILITY(U,$J,358.3,25940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25940,1,3,0)
 ;;=3^NPH w/ Dementia w/o Behavorial Disturbances
 ;;^UTILITY(U,$J,358.3,25940,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,25940,2)
 ;;=^5004174^F02.80
 ;;^UTILITY(U,$J,358.3,25941,0)
 ;;=G30.8^^98^1213^2
 ;;^UTILITY(U,$J,358.3,25941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25941,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,25941,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,25941,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,25942,0)
 ;;=A81.89^^98^1213^6
 ;;^UTILITY(U,$J,358.3,25942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25942,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,25942,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,25942,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,25943,0)
 ;;=F19.97^^98^1213^35
 ;;^UTILITY(U,$J,358.3,25943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25943,1,3,0)
 ;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
 ;;^UTILITY(U,$J,358.3,25943,1,4,0)
 ;;=4^F19.97
 ;;^UTILITY(U,$J,358.3,25943,2)
 ;;=^5003465
 ;;^UTILITY(U,$J,358.3,25944,0)
 ;;=G20.^^98^1213^28
 ;;^UTILITY(U,$J,358.3,25944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25944,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,25944,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,25944,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,25945,0)
 ;;=G20.^^98^1213^29
 ;;^UTILITY(U,$J,358.3,25945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25945,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,25945,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,25945,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,25946,0)
 ;;=G23.1^^98^1213^34
 ;;^UTILITY(U,$J,358.3,25946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25946,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,25946,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,25946,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,25947,0)
 ;;=F03.91^^98^1213^15
 ;;^UTILITY(U,$J,358.3,25947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25947,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,25947,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,25947,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,25948,0)
 ;;=F03.90^^98^1213^17
 ;;^UTILITY(U,$J,358.3,25948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25948,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,25948,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,25948,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,25949,0)
 ;;=F06.30^^98^1214^2
 ;;^UTILITY(U,$J,358.3,25949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25949,1,3,0)
 ;;=3^Depressive Disorder d/t Another Medical Condition,Unspec
 ;;^UTILITY(U,$J,358.3,25949,1,4,0)
 ;;=4^F06.30
 ;;^UTILITY(U,$J,358.3,25949,2)
 ;;=^5003056
 ;;^UTILITY(U,$J,358.3,25950,0)
 ;;=F06.31^^98^1214^3
 ;;^UTILITY(U,$J,358.3,25950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25950,1,3,0)
 ;;=3^Depressive Disorder d/t Another Medical Condition w/ Depressive Features
 ;;^UTILITY(U,$J,358.3,25950,1,4,0)
 ;;=4^F06.31
 ;;^UTILITY(U,$J,358.3,25950,2)
 ;;=^5003057
 ;;^UTILITY(U,$J,358.3,25951,0)
 ;;=F06.32^^98^1214^4
